Cardiff Oncology Inc
CRDF
$1.08+1.89%
End of day · as of Oct 12, 2026, 2:02 AM ET
Mkt cap
$238.83M
EV/Sales
373.3
P/E ratio
N/A
FY2025 Revenue
$593,000
EPS (TTM)
$-0.60
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-7732.04%
Beta
1.56
Div yield
N/A
Sector
Healthcare
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Latest reported CRDF revenue for 2025-12-31 was $593.0K. Net income was -$45.9M. Revenue was down 13.2% from 2024-12-31 to 2025-12-31. CRDF currently screens at market cap $238.8M.
Use this CRDF research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CRDF income, balance, and cash tables.
Cardiff Oncology Inc (CRDF) is a biotechnology company in the Healthcare sector.
Latest cached Cardiff Oncology Inc (CRDF) revenue for Dec 31, 2025 was $593.0K. Net income was -$45.9M. Statements: https://lician.com/financials/crdf
Cardiff Oncology Inc (CRDF) market capitalization is $238.8M on the latest cached snapshot.
Cardiff Oncology Inc (CRDF) cached previous close $1.06; day range $1.06 – $1.11; volume 297,228. Session quote: https://lician.com/quote/crdf
Cardiff Oncology Inc (CRDF) latest cached earnings event is "CRDF earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CRDF filing is 8-K · Sep 14, 2026. Filings: https://lician.com/sec/crdf